Actuate Therapeutics, Inc. Increase (Decrease) in Other Current Assets
Actuate Therapeutics, Inc. (ACTU) reported Increase (Decrease) in Other Current Assets of -$161.90 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$63.34K.
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$98.55K.
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$35.24K.
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $323.33K, a 40.27% decline year-over-year.
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2025 was -$82.28K, a 115.54% decline from fiscal 2024.
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2024 was $529.37K, a 16646.95% increase from fiscal 2023.
- Actuate Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2023 was $3.16K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$63.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$161.90K 10-Q · filed 2026-08-14 | -$197.14K derived: sum of 3 quarters · filed 2026-08-14 | $126.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$98.55K 10-Q · filed 2026-05-14 | -$133.79K derived: sum of 2 quarters · filed 2026-05-14 | $189.54K derived: sum of 3 quarters · filed 2026-05-14 | $26.29K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$35.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $288.09K derived: sum of 2 quarters · filed 2026-03-26 | $124.84K derived: sum of 3 quarters · filed 2026-08-14 | -$82.28K 10-K · filed 2026-03-26 |
| 2025-09-30 | $323.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $160.08K derived: sum of 2 quarters · filed 2026-08-14 | -$47.04K 10-Q · filed 2025-11-13 | -$220.09K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$163.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$370.38K 10-Q · filed 2026-08-14 | -$543.43K derived: sum of 3 quarters · filed 2026-08-14 | -$2.08K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$207.12K 10-Q · filed 2026-05-14 | -$380.17K derived: sum of 2 quarters · filed 2026-05-14 | $161.18K derived: sum of 3 quarters · filed 2026-05-14 | $239.38K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$173.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $368.30K derived: sum of 2 quarters · filed 2026-03-26 | $446.50K derived: sum of 3 quarters · filed 2026-03-26 | $529.37K 10-K · filed 2026-03-26 |
| 2024-09-30 | $541.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $619.56K derived: sum of 2 quarters · filed 2025-11-13 | $702.42K 10-Q · filed 2025-11-13 | $709.39K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $78.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $161.07K 10-Q · filed 2025-08-14 | $168.04K derived: sum of 3 quarters · filed 2025-08-14 | $169.48K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $82.87K 10-Q · filed 2025-05-15 | $89.83K derived: sum of 2 quarters · filed 2025-05-15 | $91.27K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $6.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $8.41K derived: sum of 2 quarters · filed 2025-03-13 | $3.16K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $1.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$3.81K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$5.25K 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |